Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Stallion Therapeutics Inc
Profile last edited on: 7/21/11      CAGE: 4PTS6      UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2007
First Award
2008
Latest Award
2008
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

741 South Limestone Street
Lexington, KY 40536
   (859) 425-1043
   edhall@uky.edu
   N/A
Location: Single
Congr. District: 06
County: Fayette

Public Profile

Stallion Therapeutics is a Lexington based start-up pharmaceutical company interested in developing neuroprotective and neurorestorative compounds for traumatic brain injury, spinal cord injury and other acute neurological disorders. The founder of Stallion is Dr. Edward D. Hall, Director of the University of Kentucky Spinal Cord & Brain Injury Research Center (SCoBIRC) and SCoBIRC Endowed Professor of Anatomy & Neurobiology, Neurology and Neurosurgery

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$128,100
Phase II Dollars
$0
Total Awarded
$128,100

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2008 1 NIH $128,100
Project Title: Novel Neuroprotectants for TBI

Key People / Management

  Ed Hall -- President

Company News

There are no news available.